Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adenocarcinoma
Scientists at State University of New York publish research in adenocarcinoma
February 10th, 2009
"Tumors arising from the anal canal are rare, comprising 1.5% of all gastrointestinal tumors in the USA. The vast majority of these anal cancers are epidermoid (cloacogenic/basaloid and squamous cell carcinomas), while adenocarcinomas reportedly occur 5% to 19% of the time," scientists writing in the Journal of Gastrointestinal Surgery report. "Because of its rarity, reports about anal adenocarcinoma are limited to small retrospective studies and case reports. Moreover, no series has directly compared outcomes between patients undergoing the various available treatment options, making it difficult to determine the optimal treatment for this aggressive cancer....
Source: Cancer Weekly (2009-02-10)
|
